Diabetologische Schwerpunktpraxis Dr. Staudenmeyer & Dr. Schiwietz

At Diabetologische Schwerpunktpraxis Dr. Staudenmeyer & Dr. Schiwietz, clinical research focuses on Nutritional and Metabolic Diseases, especially Type 2 Diabetes, obesity, and overweight. The trials are designed to assess new treatment options that may improve blood sugar control and support healthier body weight.

• Studies comparing emerging therapies with established treatments for better glycemic control
• Research on medicines aimed at reducing body weight in people with obesity or overweight
• Trials evaluating whether new approaches can improve HbA1c and overall diabetes management

This work reflects a strong interest in advancing care for people living with metabolic conditions, with an emphasis on treatments that may be more effective than current options.

The site in Lingen (Ems) is actively involved in studies for Type 2 diabetes, where the main goal is to test whether new therapies can match or outperform standard care in controlling blood sugar. These trials help clarify how well newer medicines perform in everyday diabetes treatment.

• Evaluation of therapies intended to improve blood glucose levels in adults with inadequate diabetes control
• Comparison of investigational treatments with established diabetes medications
• Focus on treatment effectiveness for people using metformin and related background therapy

The research supports the development of better options for people who need stronger and more reliable diabetes management.

Another major area of research at this health care site is obesity and weight management. The trials are exploring whether new therapies can lead to greater reductions in body weight than currently available treatments or placebo.

• Testing new medicines for their ability to support weight loss
• Comparing investigational options with existing therapies used for obesity
• Studying treatment effects in adults with overweight or obesity, including those without Type 2 diabetes

These studies aim to improve long-term management of excess weight and related metabolic health concerns.